Contact
searchSearch
HMP Global

Skin Cancer Topic Center

Featured

Rajiv Nijhawan, MD
Videos
Perioperative Care: Antibiotics, Anticoagulants, Pain Control, and Anxiolysis
05/21/2026
Rajiv Nijhawan, MD; Riya Gandhi, MA
Dermatologic surgeons can often avoid unnecessary antibiotics and interruption of anticoagulants while optimizing outcomes through careful perioperative planning, multimodal pain management, and coordinated chemoprophylaxis strategies.
Dermatologic surgeons can often avoid unnecessary antibiotics and interruption of anticoagulants while optimizing outcomes through careful perioperative planning, multimodal pain management, and coordinated chemoprophylaxis strategies.
Dermatologic surgeons can often...
05/21/2026
The Dermatologist
Vishal Patel
Videos
Neoadjuvant and Adjuvant Immunotherapy in Skin Cancer: Key Updates
05/21/2026
Vishal A Patel, MD; Riya Gandhi, MA
Emerging evidence suggests neoadjuvant immunotherapy may improve outcomes and personalize treatment planning for patients with high-risk melanoma and cutaneous squamous cell carcinoma.
Emerging evidence suggests neoadjuvant immunotherapy may improve outcomes and personalize treatment planning for patients with high-risk melanoma and cutaneous squamous cell carcinoma.
Emerging evidence suggests...
05/21/2026
The Dermatologist
Anna Bar
Videos
Interpolation Flaps in Mohs Surgery: Techniques, Planning, and Common Pitfalls
05/12/2026
Anna Bar, MD; Riya Gandhi, MA
Dr Anna Bar shares practical insights on mastering interpolation flaps in Mohs reconstruction, including how to select the right flap based on defect size and location, avoid common technical mistakes, and optimize outcomes.
Dr Anna Bar shares practical insights on mastering interpolation flaps in Mohs reconstruction, including how to select the right flap based on defect size and location, avoid common technical mistakes, and optimize outcomes.
Dr Anna Bar shares practical...
05/12/2026
The Dermatologist
Adam Sutton, MD, MBA
Videos
Recap: Surgical Reconstruction Planning for Optimal Outcomes
04/27/2026
Riya Gandhi, MA
Discover how Dr Adam Sutton approaches complex skin cancer reconstructions.
Discover how Dr Adam Sutton approaches complex skin cancer reconstructions.
Discover how Dr Adam Sutton...
04/27/2026
The Dermatologist
Orgill
Videos
Mohs Reconstruction Collaboration
04/01/2026
Riya Gandhi, MA
Dr Dennis Orgill discusses when dermatologists should involve plastic surgeons after Mohs surgery, particularly for complex defects in high-visibility areas such as the nose, eyes, and mouth.
Dr Dennis Orgill discusses when dermatologists should involve plastic surgeons after Mohs surgery, particularly for complex defects in high-visibility areas such as the nose, eyes, and mouth.
Dr Dennis Orgill discusses when...
04/01/2026
The Dermatologist
AK
News
Tirbanibulin Maintains Durable 1-Year Efficacy With Favorable Safety in Actinic Keratosis Real-World Study
03/31/2026
Riya Gandhi, MA
Extension data show sustained clearance in most lesions, with no late safety concerns and support for repeat treatment strategies.
Extension data show sustained clearance in most lesions, with no late safety concerns and support for repeat treatment strategies.
Extension data show sustained...
03/31/2026
The Dermatologist
Forehead of man during treatment for actinic keratosis
News
Tirbanibulin Demonstrates Significant Lesion Reduction and Favorable Safety in Actinic Keratosis Over Larger Treatment Fields
03/30/2026
Riya Gandhi, MA
Phase 3 data show strong efficacy and tolerability of tirbanibulin across treatment areas up to 100 cm², including with repeat treatment courses.
Phase 3 data show strong efficacy and tolerability of tirbanibulin across treatment areas up to 100 cm², including with repeat treatment courses.
Phase 3 data show strong...
03/30/2026
The Dermatologist
Vishal Patel
Videos
Managing Immunotherapy and the Future of Advanced BCC Care
03/27/2026
Vishal A Patel, MD; Riya Gandhi, MA
Dr Vishal Patel discusses key immune-related adverse events in patients receiving immunotherapy for basal cell carcinoma, including cutaneous, gastrointestinal, and endocrine toxicities.
Dr Vishal Patel discusses key immune-related adverse events in patients receiving immunotherapy for basal cell carcinoma, including cutaneous, gastrointestinal, and endocrine toxicities.
Dr Vishal Patel discusses key...
03/27/2026
The Dermatologist
Christopher B. Zachary, MD
Videos
Energy-Based Devices in the Treatment of BCCs
03/27/2026
Christopher B. Zachary, MD; Riya Gandhi, MA
Dr Christopher Zachary discusses a novel energy-based approach to treating basal cell carcinoma using controlled hyperthermia and real-time thermal monitoring.
Dr Christopher Zachary discusses a novel energy-based approach to treating basal cell carcinoma using controlled hyperthermia and real-time thermal monitoring.
Dr Christopher Zachary discusses...
03/27/2026
The Dermatologist
Vishal Patel
Videos
Defining and Treating Locally Advanced Basal Cell Carcinoma
03/27/2026
Vishal A Patel, MD; Riya Gandhi, MA
Dr Vishal Patel discusses how to define locally advanced basal cell carcinoma (BCC) in real-world practice and when surgery is no longer the best option.
Dr Vishal Patel discusses how to define locally advanced basal cell carcinoma (BCC) in real-world practice and when surgery is no longer the best option.
Dr Vishal Patel discusses how to...
03/27/2026
The Dermatologist
Stephen D. Hess, MD, PhD
Videos
Electrical Impedance Spectroscopy For Skin Cancer Screening
01/13/2026
Stephen D. Hess, MD, PhD
Dr Stephen Hess shares how he integrates the augmented intelligence-based Nevisense device into real-world dermatology practice to enhance clinical decision-making.
Dr Stephen Hess shares how he integrates the augmented intelligence-based Nevisense device into real-world dermatology practice to enhance clinical decision-making.
Dr Stephen Hess shares how he...
01/13/2026
The Dermatologist

Multimedia

Rajiv Nijhawan, MD
Videos
Perioperative Care: Antibiotics, Anticoagulants, Pain Control, and Anxiolysis
05/21/2026
Rajiv Nijhawan, MD; Riya Gandhi, MA
Dermatologic surgeons can often avoid unnecessary antibiotics and interruption of anticoagulants while optimizing outcomes through careful perioperative planning, multimodal pain management, and coordinated chemoprophylaxis strategies.
Dermatologic surgeons can often avoid unnecessary antibiotics and interruption of anticoagulants while optimizing outcomes through careful perioperative planning, multimodal pain management, and coordinated chemoprophylaxis strategies.
Dermatologic surgeons can often...
05/21/2026
The Dermatologist
Vishal Patel
Videos
Neoadjuvant and Adjuvant Immunotherapy in Skin Cancer: Key Updates
05/21/2026
Vishal A Patel, MD; Riya Gandhi, MA
Emerging evidence suggests neoadjuvant immunotherapy may improve outcomes and personalize treatment planning for patients with high-risk melanoma and cutaneous squamous cell carcinoma.
Emerging evidence suggests neoadjuvant immunotherapy may improve outcomes and personalize treatment planning for patients with high-risk melanoma and cutaneous squamous cell carcinoma.
Emerging evidence suggests...
05/21/2026
The Dermatologist
Anna Bar
Videos
Interpolation Flaps in Mohs Surgery: Techniques, Planning, and Common Pitfalls
05/12/2026
Anna Bar, MD; Riya Gandhi, MA
Dr Anna Bar shares practical insights on mastering interpolation flaps in Mohs reconstruction, including how to select the right flap based on defect size and location, avoid common technical mistakes, and optimize outcomes.
Dr Anna Bar shares practical insights on mastering interpolation flaps in Mohs reconstruction, including how to select the right flap based on defect size and location, avoid common technical mistakes, and optimize outcomes.
Dr Anna Bar shares practical...
05/12/2026
The Dermatologist
Adam Sutton, MD, MBA
Videos
Recap: Surgical Reconstruction Planning for Optimal Outcomes
04/27/2026
Riya Gandhi, MA
Discover how Dr Adam Sutton approaches complex skin cancer reconstructions.
Discover how Dr Adam Sutton approaches complex skin cancer reconstructions.
Discover how Dr Adam Sutton...
04/27/2026
The Dermatologist
Orgill
Videos
Mohs Reconstruction Collaboration
04/01/2026
Riya Gandhi, MA
Dr Dennis Orgill discusses when dermatologists should involve plastic surgeons after Mohs surgery, particularly for complex defects in high-visibility areas such as the nose, eyes, and mouth.
Dr Dennis Orgill discusses when dermatologists should involve plastic surgeons after Mohs surgery, particularly for complex defects in high-visibility areas such as the nose, eyes, and mouth.
Dr Dennis Orgill discusses when...
04/01/2026
The Dermatologist
Vishal Patel
Videos
Managing Immunotherapy and the Future of Advanced BCC Care
03/27/2026
Vishal A Patel, MD; Riya Gandhi, MA
Dr Vishal Patel discusses key immune-related adverse events in patients receiving immunotherapy for basal cell carcinoma, including cutaneous, gastrointestinal, and endocrine toxicities.
Dr Vishal Patel discusses key immune-related adverse events in patients receiving immunotherapy for basal cell carcinoma, including cutaneous, gastrointestinal, and endocrine toxicities.
Dr Vishal Patel discusses key...
03/27/2026
The Dermatologist
Christopher B. Zachary, MD
Videos
Energy-Based Devices in the Treatment of BCCs
03/27/2026
Christopher B. Zachary, MD; Riya Gandhi, MA
Dr Christopher Zachary discusses a novel energy-based approach to treating basal cell carcinoma using controlled hyperthermia and real-time thermal monitoring.
Dr Christopher Zachary discusses a novel energy-based approach to treating basal cell carcinoma using controlled hyperthermia and real-time thermal monitoring.
Dr Christopher Zachary discusses...
03/27/2026
The Dermatologist
Vishal Patel
Videos
Defining and Treating Locally Advanced Basal Cell Carcinoma
03/27/2026
Vishal A Patel, MD; Riya Gandhi, MA
Dr Vishal Patel discusses how to define locally advanced basal cell carcinoma (BCC) in real-world practice and when surgery is no longer the best option.
Dr Vishal Patel discusses how to define locally advanced basal cell carcinoma (BCC) in real-world practice and when surgery is no longer the best option.
Dr Vishal Patel discusses how to...
03/27/2026
The Dermatologist
Stephen D. Hess, MD, PhD
Videos
Electrical Impedance Spectroscopy For Skin Cancer Screening
01/13/2026
Stephen D. Hess, MD, PhD
Dr Stephen Hess shares how he integrates the augmented intelligence-based Nevisense device into real-world dermatology practice to enhance clinical decision-making.
Dr Stephen Hess shares how he integrates the augmented intelligence-based Nevisense device into real-world dermatology practice to enhance clinical decision-making.
Dr Stephen Hess shares how he...
01/13/2026
The Dermatologist
Dr Julia Siegel
Videos
Conversations About Photoprotection During the Pandemic
10/21/2021
Julia A. Siegel, MD
Dr Julia Siegel discusses the importance of photoprotection, sunscreen, and how the pandemic has affected patient skin exams.
Dr Julia Siegel discusses the importance of photoprotection, sunscreen, and how the pandemic has affected patient skin exams.
Dr Julia Siegel discusses the...
10/21/2021
The Dermatologist
Dr Lisa Swanson
Videos
Pediatric Atopic Dermatitis: Diagnosis, Treatment Selection, and Long-Term Health Considerations
11/03/2026
Elizabeth Swanson, MD; Jessica Garlewicz
Lisa Swanson, MD, emphasizes the importance of early, effective treatment of pediatric atopic dermatitis, highlighting emerging evidence that dupilumab may improve growth and bone health outcomes while potentially reducing the risk of atopic...
Lisa Swanson, MD, emphasizes the importance of early, effective treatment of pediatric atopic dermatitis, highlighting emerging evidence that dupilumab may improve growth and bone health outcomes while potentially reducing the risk of atopic...
Lisa Swanson, MD, emphasizes the...
11/03/2026
The Dermatologist
KOL Roundtable
Videos
Type 2 Inflammation as an Underlying Disease Driver
11/02/2026
Raj Chovatiya, MD, PhD; Tina Bhutani, MD, MAS; Daniel C. Butler, MD; Jason Ezra Hawkes, MD, MS, FAAD
Dr Raj Chovatiya moderates an expert roundtable with Drs Tina Bhutani, Daniel Butler, and Jason Hawkes, exploring how type 2 inflammation drives chronic inflammatory skin diseases, including atopic dermatitis, prurigo nodularis, and chronic...
Dr Raj Chovatiya moderates an expert roundtable with Drs Tina Bhutani, Daniel Butler, and Jason Hawkes, exploring how type 2 inflammation drives chronic inflammatory skin diseases, including atopic dermatitis, prurigo nodularis, and chronic...
Dr Raj Chovatiya moderates an...
11/02/2026
The Dermatologist
Brian Kim
Videos
From Cytokines to Clinic: Translating Type 2 Biology Into Prurigo Nodularis Treatment
11/01/2026
Brian Kim, MD, MTR, FAAD; Riya Gandhi, MA
Dr Brian Kim explores how IL-4 and IL-13 drive itch, fibrosis, and nodule formation in prurigo nodularis through neuroimmune and type 2 inflammatory pathways.
Dr Brian Kim explores how IL-4 and IL-13 drive itch, fibrosis, and nodule formation in prurigo nodularis through neuroimmune and type 2 inflammatory pathways.
Dr Brian Kim explores how IL-4...
11/01/2026
The Dermatologist
Goldberg
Videos
Image-Guided SRT for Nonmelanoma Skin Cancer
10/16/2026
David Goldberg, MD, JD; Riya Gandhi, MA
Dr David Goldberg discusses how high-resolution ultrasound guidance is improving superficial radiation therapy for nonmelanoma skin cancers.
Dr David Goldberg discusses how high-resolution ultrasound guidance is improving superficial radiation therapy for nonmelanoma skin cancers.
Dr David Goldberg discusses how...
10/16/2026
The Dermatologist
Dr Martina Porter
Videos
Expert Insights: Povorcitinib for Hidradenitis Suppurativa
10/15/2026
Martina Porter, MD; Jessica Garlewicz
Povorcitinib improved HiSCR50 responses in moderate-to-severe hidradenitis suppurativa, with higher dosing potentially benefiting patients with more severe disease and a generally favorable safety profile through 54 weeks.
Povorcitinib improved HiSCR50 responses in moderate-to-severe hidradenitis suppurativa, with higher dosing potentially benefiting patients with more severe disease and a generally favorable safety profile through 54 weeks.
Povorcitinib improved HiSCR50...
10/15/2026
The Dermatologist
Dr Lisa Swanson
Videos
Biologic Decision-Making for Moderate-to-Severe Atopic Dermatitis
10/15/2026
Jessica Garlewicz; Elizabeth Swanson, MD
Individualized management of moderate-to-severe atopic dermatitis should consider overall disease burden, patient-specific factors and preferences, and clear treatment expectations to guide systemic therapy selection and support adherence.
Individualized management of moderate-to-severe atopic dermatitis should consider overall disease burden, patient-specific factors and preferences, and clear treatment expectations to guide systemic therapy selection and support adherence.
Individualized management of...
10/15/2026
The Dermatologist
Dr Raj Chovatiya
Videos
Optimizing Biologic Treatment Decisions in Moderate-to-Severe Atopic Dermatitis
10/15/2026
Raj Chovatiya, MD, PhD; Jessica Garlewicz
Raj Chovatiya, MD, PhD, emphasizes individualized biologic selection, shared decision-making, and adequate treatment optimization before switching therapies in patients with moderate-to-severe atopic dermatitis.
Raj Chovatiya, MD, PhD, emphasizes individualized biologic selection, shared decision-making, and adequate treatment optimization before switching therapies in patients with moderate-to-severe atopic dermatitis.
Raj Chovatiya, MD, PhD,...
10/15/2026
The Dermatologist
cohen
Videos
Targeting Type 2 Inflammation in Eczema, Prurigo Nodularis, and Urticaria
10/01/2026
Jeffrey M. Cohen, MD; Riya Gandhi, MA
Dr Jeffrey Cohen discusses how IL-4, IL-13, and IL-31 drive inflammation and itch across eczema, prurigo nodularis, and chronic urticaria.
Dr Jeffrey Cohen discusses how IL-4, IL-13, and IL-31 drive inflammation and itch across eczema, prurigo nodularis, and chronic urticaria.
Dr Jeffrey Cohen discusses how...
10/01/2026
The Dermatologist
Goldberg
Videos
Prolactin Receptor Inhibition for Hair Loss: A New Frontier in Hair Regrowth
09/28/2026
David Goldberg, MD, JD; Riya Gandhi, MA
Dr David Goldberg discusses emerging prolactin receptor–targeted therapies for androgenetic alopecia and other hair disorders.
Dr David Goldberg discusses emerging prolactin receptor–targeted therapies for androgenetic alopecia and other hair disorders.
Dr David Goldberg discusses...
09/28/2026
The Dermatologist
Bloom
Videos
Biostimulatory Fillers in Facial Rejuvenation
09/28/2026
Jason Bloom, MD, FACS; Riya Gandhi, MA
Dr Jason Bloom discusses the evolution of facial rejuvenation from line-filling to comprehensive facial balancing through volumization and biostimulation.
Dr Jason Bloom discusses the evolution of facial rejuvenation from line-filling to comprehensive facial balancing through volumization and biostimulation.
Dr Jason Bloom discusses the...
09/28/2026
The Dermatologist

News

AK
News
Tirbanibulin Maintains Durable 1-Year Efficacy With Favorable Safety in Actinic Keratosis Real-World Study
03/31/2026
Riya Gandhi, MA
Extension data show sustained clearance in most lesions, with no late safety concerns and support for repeat treatment strategies.
Extension data show sustained clearance in most lesions, with no late safety concerns and support for repeat treatment strategies.
Extension data show sustained...
03/31/2026
The Dermatologist
Forehead of man during treatment for actinic keratosis
News
Tirbanibulin Demonstrates Significant Lesion Reduction and Favorable Safety in Actinic Keratosis Over Larger Treatment Fields
03/30/2026
Riya Gandhi, MA
Phase 3 data show strong efficacy and tolerability of tirbanibulin across treatment areas up to 100 cm², including with repeat treatment courses.
Phase 3 data show strong efficacy and tolerability of tirbanibulin across treatment areas up to 100 cm², including with repeat treatment courses.
Phase 3 data show strong...
03/30/2026
The Dermatologist
Psoriasis on hand
News
Italian Dermatologists Propose Practical Criteria to Define Moderate Psoriasis
11/03/2026
Jessica Garlewicz
A panel of Italian dermatologists proposed practical criteria for defining moderate psoriasis, emphasizing the importance of combining objective severity measures with patient-reported outcomes to improve treatment selection and reduce...
A panel of Italian dermatologists proposed practical criteria for defining moderate psoriasis, emphasizing the importance of combining objective severity measures with patient-reported outcomes to improve treatment selection and reduce...
A panel of Italian...
11/03/2026
The Dermatologist
Physician talk with overweight man
News
Psoriasis and Obesity Share Inflammatory Pathways, Highlighting Need for Integrated Care
11/03/2026
Jessica Garlewicz
Psoriasis and obesity share inflammatory pathways that may contribute to greater disease severity, reduced treatment response, and increased metabolic complications.
Psoriasis and obesity share inflammatory pathways that may contribute to greater disease severity, reduced treatment response, and increased metabolic complications.
Psoriasis and obesity share...
11/03/2026
The Dermatologist
Scientist in lab
News
Single-Cell and Spatial Transcriptomics Reveal New Insights Into Psoriasis Pathogenesis
11/03/2026
Jessica Garlewicz
Advances in single-cell RNA sequencing and spatial transcriptomics are reshaping understanding of psoriasis pathogenesis, highlighting the role of cellular interactions and tissue microenvironments in disease heterogeneity.
Advances in single-cell RNA sequencing and spatial transcriptomics are reshaping understanding of psoriasis pathogenesis, highlighting the role of cellular interactions and tissue microenvironments in disease heterogeneity.
Advances in single-cell RNA...
11/03/2026
The Dermatologist
Psoriasis on foot
News
Psoriasis-Atopic Dermatitis Overlap Phenotype Presents Diagnostic and Therapeutic Challenges
11/03/2026
Jessica Garlewicz
Patients exhibiting overlapping features of psoriasis and atopic dermatitis may present distinct diagnostic and therapeutic challenges due to mixed inflammatory pathways.
Patients exhibiting overlapping features of psoriasis and atopic dermatitis may present distinct diagnostic and therapeutic challenges due to mixed inflammatory pathways.
Patients exhibiting overlapping...
11/03/2026
The Dermatologist
Physician with dermatoscope
News
Dermoscopy With UV Imaging May Help Differentiate Mycosis Fungoides, Psoriasis, and Atopic Dermatitis
11/03/2026
Jessica Garlewicz
Dermoscopy combined with ultraviolet imaging may help distinguish early-stage mycosis fungoides, psoriasis, and atopic dermatitis.
Dermoscopy combined with ultraviolet imaging may help distinguish early-stage mycosis fungoides, psoriasis, and atopic dermatitis.
Dermoscopy combined with...
11/03/2026
The Dermatologist
Atopic dermatitis
News
Emerging Biomarkers May Improve Precision Diagnosis and Personalized Treatment in Atopic Dermatitis
11/03/2026
Jessica Garlewicz
Emerging immunoassay-based biomarkers may improve disease assessment and support personalized treatment strategies for patients with atopic dermatitis.
Emerging immunoassay-based biomarkers may improve disease assessment and support personalized treatment strategies for patients with atopic dermatitis.
Emerging immunoassay-based...
11/03/2026
The Dermatologist
Two doctors in a lab
News
Salivary Biomarkers May Offer Noninvasive Approach to Monitoring Atopic Dermatitis
11/03/2026
Jessica Garlewicz
Salivary biomarkers may provide a noninvasive approach to monitoring stress, sleep quality, and disease severity in patients with atopic dermatitis.
Salivary biomarkers may provide a noninvasive approach to monitoring stress, sleep quality, and disease severity in patients with atopic dermatitis.
Salivary biomarkers may provide...
11/03/2026
The Dermatologist
News
Dupilumab Associated With Improved Height Growth and Bone Mineralization Markers in Children With Severe Atopic Dermatitis
11/03/2026
Jessica Garlewicz
Dupilumab treatment was associated with improvements in height growth and bone mineralization markers among children with severe atopic dermatitis.
Dupilumab treatment was associated with improvements in height growth and bone mineralization markers among children with severe atopic dermatitis.
Dupilumab treatment was...
11/03/2026
The Dermatologist
diet
News
Diet May Influence Skin Barrier Function in Atopic Dermatitis
11/02/2026
Coleen Stern, MA
Diet may represent a modifiable factor in skin barrier integrity and atopic dermatitis, but inconsistent findings prevent definitive dietary recommendations.
Diet may represent a modifiable factor in skin barrier integrity and atopic dermatitis, but inconsistent findings prevent definitive dietary recommendations.
Diet may represent a modifiable...
11/02/2026
The Dermatologist
dermatitis
News
Atopic Dermatitis Diagnosis Requires Careful Differentiation From Inflammatory, Infectious, and Systemic Conditions
10/28/2026
Jessica Garlewicz
Accurate diagnosis of atopic dermatitis requires careful differentiation from inflammatory, infectious, autoimmune, and neoplastic conditions that may present with overlapping clinical features.
Accurate diagnosis of atopic dermatitis requires careful differentiation from inflammatory, infectious, autoimmune, and neoplastic conditions that may present with overlapping clinical features.
Accurate diagnosis of atopic...
10/28/2026
The Dermatologist
october 2026

Current Issue

October 2026
Volume 34
Issue 7
Current Issue
Issue Archive

Recent News

skin cancer
News
Phase 3 Trial Demonstrates Significant Benefits of Libtayo in High-Risk Cutaneous Squamous Cell Carcinoma
01/14/2025
Jessica Garlewicz
Regeneron Pharmaceuticals has announced promising interim results from the Phase 3 C-POST trial, evaluating the PD-1 inhibitor Libtayo (cemiplimab).
Regeneron Pharmaceuticals has announced promising interim results from the Phase 3 C-POST trial, evaluating the PD-1 inhibitor Libtayo (cemiplimab).
Regeneron Pharmaceuticals has...
01/14/2025
The Dermatologist
doctor
News
Pongamia Pinnata Extract as a Potential Treatment for Skin Cancer
12/30/2024
Riya Gandhi, MA
New research reveals Pongamia pinnata’s powerful potential as an anti-cancer agent for skin tumors, combining traditional knowledge with cutting-edge molecular science.
New research reveals Pongamia pinnata’s powerful potential as an anti-cancer agent for skin tumors, combining traditional knowledge with cutting-edge molecular science.
New research reveals Pongamia...
12/30/2024
The Dermatologist
skin cancer
News
Non-Melanoma Skin Cancer Event Rates: Considerations for Clinical Trial Design
08/22/2024
Jessica Garlewicz
Researchers investigated clinical risk factors and event rates for the development of new non-melanoma skin cancer.
Researchers investigated clinical risk factors and event rates for the development of new non-melanoma skin cancer.
Researchers investigated...
08/22/2024
The Dermatologist
skin of color skin examination
News
Skin Cancers Associated with Genodermatoses in Patients with Skin of Color
08/09/2024
Jessica Garlewicz
Researchers aimed to identify notable characteristics in location, frequency, and severity of cutaneous findings, along with the median age of skin cancers in patients with skin of color.
Researchers aimed to identify notable characteristics in location, frequency, and severity of cutaneous findings, along with the median age of skin cancers in patients with skin of color.
Researchers aimed to identify...
08/09/2024
The Dermatologist
Lab slide
News
Esophageal Squamous Cell Carcinoma Under Iodine Staining
08/09/2024
Jessica Garlewicz
Researchers aimed to evaluate the effects of texture and color enhancement imaging on improving the endoscopic visibility of esophageal squamous cell carcinoma under iodine staining.
Researchers aimed to evaluate the effects of texture and color enhancement imaging on improving the endoscopic visibility of esophageal squamous cell carcinoma under iodine staining.
Researchers aimed to evaluate...
08/09/2024
The Dermatologist
Physicians in a lab
News
Establishing a Novel Model for Studying Neural Invasion in Non-Melanoma Skin Cancer
05/15/2024
Jessica Garlewicz
Researchers aimed to develop a 3-dimensional model of neural invasion in squamous cell carcinoma to better understand its underlying biologic mechanisms, which are still poorly understood.
Researchers aimed to develop a 3-dimensional model of neural invasion in squamous cell carcinoma to better understand its underlying biologic mechanisms, which are still poorly understood.
Researchers aimed to develop a...
05/15/2024
The Dermatologist
Skin cancer exam
News
Interferon-Gamma as a Prognostic Marker in Macroscopic Stage III Melanoma
05/08/2024
Jessica Garlewicz
Researchers aimed to identify prognostic and predictive biomarkers for adjuvant anti-PD-1 therapy in patients with macroscopic stage III melanoma.
Researchers aimed to identify prognostic and predictive biomarkers for adjuvant anti-PD-1 therapy in patients with macroscopic stage III melanoma.
Researchers aimed to identify...
05/08/2024
The Dermatologist
Older man testing blood sugar
News
Relationship Between Insulin Use, Social Determinants of Health, and Non-Melanoma Skin Cancer
05/07/2024
Jessica Garlewicz
Researchers aimed to investigate the relationship between insulin use, social determinants of health, and non-melanoma skin cancer risk among individuals with diabetes.
Researchers aimed to investigate the relationship between insulin use, social determinants of health, and non-melanoma skin cancer risk among individuals with diabetes.
Researchers aimed to investigate...
05/07/2024
The Dermatologist
Strand of DNA
News
Regulatory T Cell Involvement in Melanoma Prognosis and Treatment Strategy
03/28/2024
Jessica Garlewicz
Researchers analyzed single-cell RNA sequencing data alongside clinical information.
Researchers analyzed single-cell RNA sequencing data alongside clinical information.
Researchers analyzed single-cell...
03/28/2024
The Dermatologist
Melanoma
News
Role of Cuproptosis and Hippo Pathway in the Prognosis of Skin Cutaneous Melanoma
03/28/2024
Jessica Garlewicz
Researchers examined the correlation between cuproptosis-related and Hippo pathway-related genes and melanoma prognosis using public databases and experimental validation.
Researchers examined the correlation between cuproptosis-related and Hippo pathway-related genes and melanoma prognosis using public databases and experimental validation.
Researchers examined the...
03/28/2024
The Dermatologist
Collagen and vitamin drop skin cell
News
HHS Outlines Conditional Enforcement Discretion for 6 Compounded Peptides
10/29/2026
Coleen Stern, MA
The US Department of Health and Human Services has outlined an interim enforcement policy for compounding 6 peptide bulk drug substances while their inclusion on the section 503A bulks list is considered through rulemaking.
The US Department of Health and Human Services has outlined an interim enforcement policy for compounding 6 peptide bulk drug substances while their inclusion on the section 503A bulks list is considered through rulemaking.
The US Department of Health and...
10/29/2026
The Dermatologist
cream
News
Behenic Acid and Ceramide Creams Accelerate Skin Barrier Recovery
10/13/2026
Coleen Stern, MA
Creams containing behenic acid (BA) or ceramide (CER) accelerated recovery of experimentally damaged skin, suggesting that both lipid components may support topical formulations designed to restore barrier function.
Creams containing behenic acid (BA) or ceramide (CER) accelerated recovery of experimentally damaged skin, suggesting that both lipid components may support topical formulations designed to restore barrier function.
Creams containing behenic acid...
10/13/2026
The Dermatologist
FDA Alerts
FDA Approves Rhapsido as First Treatment for Symptomatic Dermographism in Adults
10/08/2026
Jessica Garlewicz
On October 7, 2026, the US Food and Drug Administration approved remibrutinib, an oral, highly selective Bruton’s tyrosine kinase inhibitor, as the first treatment for adults with symptomatic dermographism inadequately controlled by H1...
On October 7, 2026, the US Food and Drug Administration approved remibrutinib, an oral, highly selective Bruton’s tyrosine kinase inhibitor, as the first treatment for adults with symptomatic dermographism inadequately controlled by H1...
On October 7, 2026, the US Food...
10/08/2026
The Dermatologist
GLP-1
News
GLP-1 Receptor Agonists Linked to Lower Mortality, Cardiovascular Risk in Patients With Psoriasis
10/07/2026
Jessica Garlewicz
Glucagon-like peptide-1 receptor agonist treatment was associated with lower all-cause mortality and reduced cardiovascular and psychiatric comorbidity risks among patients with psoriasis and obesity or diabetes.
Glucagon-like peptide-1 receptor agonist treatment was associated with lower all-cause mortality and reduced cardiovascular and psychiatric comorbidity risks among patients with psoriasis and obesity or diabetes.
Glucagon-like peptide-1 receptor...
10/07/2026
The Dermatologist
Smiling woman touching neck
News
Anatomy-Driven Model Aims to Prevent GLP-1 RA–Associated Facial Aging
10/01/2026
Coleen Stern, MA
Researchers propose an anatomy-driven framework for identifying patients at risk for rapid, region-specific facial volume loss and intervening before visible facial aging progresses.
Researchers propose an anatomy-driven framework for identifying patients at risk for rapid, region-specific facial volume loss and intervening before visible facial aging progresses.
Researchers propose an...
10/01/2026
The Dermatologist
dkin
News
Review Reframes Skin Barrier as an Integrated Defense System
09/30/2026
Coleen Stern, MA
The skin barrier functions as an interconnected physical, chemical, immune, and microbial defense system rather than a single structural layer.
The skin barrier functions as an interconnected physical, chemical, immune, and microbial defense system rather than a single structural layer.
The skin barrier functions as an...
09/30/2026
The Dermatologist
FDA Alerts
FDA Approves Baricitinib for Adolescents With Severe Alopecia Areata
09/28/2026
Riya Gandhi, MA
FDA has expanded the indication for baricitinib (Olumiant) to include adolescents aged 12 years and older with severe alopecia areata, based on results from the Phase 3 BRAVE-AA-PEDS trial.
FDA has expanded the indication for baricitinib (Olumiant) to include adolescents aged 12 years and older with severe alopecia areata, based on results from the Phase 3 BRAVE-AA-PEDS trial.
FDA has expanded the indication...
09/28/2026
The Dermatologist
Global travel
News
Global Psoriasis Burden Nearly Doubled Over 3 Decades, Economic Costs Reach $149 Billion
09/03/2026
Jessica Garlewicz
Investigators assessed trends in psoriasis cases, effects on quality of life, and associated economic costs.
Investigators assessed trends in psoriasis cases, effects on quality of life, and associated economic costs.
Investigators assessed trends in...
09/03/2026
The Dermatologist
FDA Alerts
FDA Approves Lisraya as First Oral Therapy for Adult Dermatomyositis
08/31/2026
Coleen Stern, MA
For dermatologists and patients, this approval provides a new alternative targeting the JAK-mediated inflammation that damages the muscles and skin in dermatomyositis to control both cutaneous and systemic manifestations.
For dermatologists and patients, this approval provides a new alternative targeting the JAK-mediated inflammation that damages the muscles and skin in dermatomyositis to control both cutaneous and systemic manifestations.
For dermatologists and patients,...
08/31/2026
The Dermatologist
FDA Alerts
FDA Grants Accelerated Approval to Tudriqev for PD-1-Refractory Advanced Melanoma
08/07/2026
Jessica Garlewicz
The US Food and Drug Administration (FDA) has granted accelerated approval to Tudriqev (vusolimogene oderparepvec-wtpg) in combination with nivolumab for the treatment of adults with unresectable advanced cutaneous melanoma.
The US Food and Drug Administration (FDA) has granted accelerated approval to Tudriqev (vusolimogene oderparepvec-wtpg) in combination with nivolumab for the treatment of adults with unresectable advanced cutaneous melanoma.
The US Food and Drug...
08/07/2026
The Dermatologist

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use